ME
ME company profile
Latest price
As of — · Market data by Massive
Market cap
—
Volume
—
Previous close
—
Day range
—
Listed
—
Coverage
4 articles
Price performance
Recent trading
Newsroom
Latest ME coverage
23andMe Exploring A Sale Amid Financial Uncertainty: What This Means For Investors!
23andMe is exploring a potential sale after a tumultuous period marked by a failed buyout proposal from CEO Anne Wojcicki, an 82% stock decline in 2024, mass resignations of independent directors, and a 40% workforce reduction.
23andMe: Is This Genetic Data Giant is Now a Prime Acquisition Target?
23andMe, a pioneer in consumer genetics, is once again at the center of acquisition talks, with co-founder and CEO Anne Wojcicki reportedly open to third-party takeovers.
Democratizing Healthcare: How QC Kinetix (Freeport) is Making Regenerative Medicine Accessible
[ad_1] Freeport, ME – (NewMediaWire) – May 5, 2023 – QC Kinetix (Freeport) is revolutionizing the way chronic pain and sports injuries are treated by offering all-natural regenerative medicine treatments that provide a viable alternative to invasive surgeries. Located in Freeport, ME, this innovative pain control clinic provides patients wi
Nucleus One, a Leading Consulting Firm Focused on the Cannabis Industry, Becomes Opus Consulting
[ad_1] Portland, ME / Boston, MA – (NewMediaWire) – October 5, 2021 – As the cannabis industry has grown and evolved, so has the Nucleus One team and the demand for its services. This growth has reached a point where the cannabis services no longer fit in a segregated division of the company but are now ...